Zymeworks Stock Price Down 7.2 percent Time to Sell?
ZYME Stock | USD 13.06 0.08 0.61% |
About 73% of Zymeworks Common's investor base is looking to short. The analysis of the overall investor sentiment regarding Zymeworks Common Stock suggests that many traders are alarmed. The current market sentiment, together with Zymeworks Common's historical and current headlines, can help investors time the market. In addition, many technical investors use Zymeworks Common Stock stock news signals to limit their universe of possible portfolio assets.
Zymeworks |
Zymeworks Inc. dropped 7.2 percent during mid-day trading on Monday . The stock traded as low as 13.23 and last traded at 13.23. Approximately 124,564 shares traded hands during trading, a decline of 80 percent from the average daily volume of 610,564 shares. The stock had previously closed at 14.25. Wall Street
Read at thelincolnianonline.com
Zymeworks Common Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Zymeworks Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zymeworks Common Fundamental Analysis
We analyze Zymeworks Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zymeworks Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zymeworks Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Zymeworks Common is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Zymeworks Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zymeworks Common stock to make a market-neutral strategy. Peer analysis of Zymeworks Common could also be used in its relative valuation, which is a method of valuing Zymeworks Common by comparing valuation metrics with similar companies.
Peers
Zymeworks Common Related Equities
INZY | Inozyme Pharma | 9.56 | ||||
TERN | Terns Pharmaceuticals | 5.17 | ||||
ARWR | Arrowhead Pharmaceuticals | 2.79 | ||||
PTGX | Protagonist Therapeutics | 2.72 | ||||
BPMC | Blueprint Medicines | 0.87 | ||||
RVMD | Revolution Medicines | 0.53 | ||||
YMAB | Y MAbs | 0.19 | ||||
CYTK | Cytokinetics | 0.1 | ||||
TVTX | Travere Therapeutics | 0.11 | ||||
APLS | Apellis Pharmaceuticals | 1.09 | ||||
AKRO | Akero Therapeutics | 1.54 | ||||
ANNX | Annexon | 1.81 | ||||
DAWN | Day One | 1.86 | ||||
MRSN | Mersana Therapeutics | 2.75 | ||||
STOK | Stoke Therapeutics | 3.63 | ||||
SNDX | Syndax Pharmaceuticals | 3.98 | ||||
PRQR | ProQR Therapeutics | 4.06 | ||||
ALEC | Alector | 4.33 | ||||
RLAY | Relay Therapeutics | 5.74 | ||||
CABA | Cabaletta Bio | 5.76 | ||||
EDIT | Editas Medicine | 5.83 | ||||
BLUE | Bluebird Bio | 6.67 | ||||
ZNTL | Zentalis Pharmaceuticals | 7.20 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |